MiR-542-3p suppresses osteoblast cell proliferation and differentiation, targets BMP-7 signaling and inhibits bone formation

Cell Death and Disease

Volumn 5, Issue 2, 2014, Pages

  Kureel, J ^a   Dixit, M ^a   Tyagi, A M ^a   Mansoori, M N ^a   Srivastava, K ^a   Raghuvanshi, A ^b   Maurya, R ^b   Trivedi, R ^a   Goel, A ^b   Singh, D ^a  

^a Division of Endocrinology   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

bone formation; bone strength; microRNAs; osteoblast differentiation; proliferation; trabecular microarchitecture

Indexed keywords

MICRORNA; MICRORNA 542 3P; OSTEOGENIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; SURVIVIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE DEVELOPMENT; BONE STRENGTH; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL;

ANIMALS; BONE MORPHOGENETIC PROTEIN 7; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; MICE, INBRED BALB C; MICRORNAS; OSTEOBLASTS; OSTEOGENESIS; SIGNAL TRANSDUCTION;

EID: 84896763527     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.4     Document Type: Article

References (41)

1. Eskildsen T, Taipaleenmaki H, Stenvang J, Abdallah BM, Ditzel N, Nossent AY et al. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci USA 2011; 108: 6139-6144.
2. Dong J, Cui X, Jiang Z, Sun J. MicroRNA-23a modulates tumor necrosis factor-Alpha-induced osteoblasts apoptosis by directly targeting Fas. J Cell Biochem 2013; 114: 2738-2745.
3. Hassan MQ, Maeda Y, Taipaleenmaki H, Zhang W, Jafferji M, Gordon JA et al. miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells. J Biol Chem 2012; 287: 42084-42092.
4. Hu R, Li H, Liu W, Yang L, Tan YF, Luo XH. Targeting miRNAs in osteoblast differentiation and bone formation. Expert Opin Ther Targets 2010; 14: 1109-1120.
5. Inose H, Ochi H, Kimura A, Fujita K, Xu R, Sato S et al. A microRNA regulatory mechanism of osteoblast differentiation. Proc Natl Acad Sci USA 2009; 106: 20794-20799.
6. Li H, Xie H, Liu W, Hu R, Huang B, Tan YF et al. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest 2009; 119: 3666-3677.
7. Dong S, Yang B, Guo H, Kang F. MicroRNAs regulate osteogenesis and chondrogenesis. Biochem Biophys Res Commun 2012; 418: 587-591.
8. Bae Y, Yang T, Zeng HC, Campeau PM, Chen Y, Bertin T et al. miRNA-34c regulates Notch signaling during bone development. Hum Mol Genet 2012; 21: 2991-3000.
9. Gao J, Yang T, Han J, Yan K, Qiu X, Zhou Y et al. MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow. J Cell Biochem 2011; 112: 1844-1856.
10. Guo J, Ren F, Wang Y, Li S, Gao Z, Wang X et al. miR-764-5p promotes osteoblast differentiation through inhibition of CHIP/STUB1 expression. J Bone Miner Res 2012; 27: 1607-1618.
11. Taipaleenmaki H, Bjerre Hokland L, Chen L, Kauppinen S, Kassem M. Mechanisms in endocrinology: Micro-RNAs: Targets for enhancing osteoblast differentiation and bone formation. Eur J Endocrinol 2012; 166: 359-371.
12. Li Z, Hassan MQ, Volinia S, van Wijnen AJ, Stein JL, Croce CM et al. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci USA 2008; 105: 13906-13911.
13. Huang J, Zhao L, Xing L, Chen D. MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 2010; 28: 357-364.
14. Itoh T, Nozawa Y, Akao Y. MicroRNA-141 and-200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. J Biol Chem 2009; 284: 19272-19279.
15. Zhang J, Tu Q, Bonewald LF, He X, Stein G, Lian J et al. Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1. J Bone Miner Res 2011; 26: 1953-1963.
16. Itoh T, Takeda S, Akao Y. MicroRNA-208 modulates BMP-2-stimulated mouse preosteoblast differentiation by directly targeting V-ets erythroblastosis virus E26 oncogene homolog 1. J Biol Chem 2010; 285: 27745-27752.
17. Sato MM, Nashimoto M, Katagiri T, Yawaka Y, Tamura M. Bone morphogenetic protein-2 down-regulates miR-206 expression by blocking its maturation process. Biochem Biophys Res Commun 2009; 383: 125-129.
18. Bhargavan B, Singh D, Gautam AK, Mishra JS, Kumar A, Goel A et al. Medicarpin, a legume phytoalexin, stimulates osteoblast differentiation and promotes peak bone mass achievement in rats: Evidence for estrogen receptor beta-mediated osteogenic action of medicarpin. J Nutr Biochem 2012; 23: 27-38.
19. Oneyama C, Morii E, Okuzaki D, Takahashi Y, Ikeda J, Wakabayashi N et al. MicroRNA-mediated upregulation of integrin-linked kinase promotes Src-induced tumor progression. Oncogene 2012; 31: 1623-1635.
20. Yoon S, Choi YC, Lee S, Jeong Y, Yoon J, Baek K. Induction of growth arrest by miR-542-3p that targets survivin. FEBS Lett 2010; 584: 4048-4052.
21. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004; 22: 233-241.
22. Gautschi OP, Frey SP, Zellweger R. Bone morphogenetic proteins in clinical applications. ANZ J Surg 2007; 77: 626-631.
23. Zhu W, Rawlins BA, Boachie-Adjei O, Myers ER, Arimizu J, Choi E et al. Combined bone morphogenetic protein-2 and-7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J Bone Miner Res 2004; 19: 2021-2032.
24. ten Dijke P, Korchynskyi O, Valdimarsdottir G, Goumans MJ. Controlling cell fate by bone morphogenetic protein receptors. Mol Cell Endocrinol 2003; 211: 105-113.
25. Shimizu T, Kayamori T, Murayama C, Miyamoto A. Bone morphogenetic protein (BMP)-4 and BMP-7 suppress granulosa cell apoptosis via different pathways: BMP-4 via PI3K/PDK-1/Akt and BMP-7 via PI3K/PDK-1/PKC. Biochem Biophys Res Commun 2012; 417: 869-873.
26. Belyanskaya LL, Hopkins-Donaldson S, Kurtz S, Simoes-Wust AP, Yousefi S, Simon HU et al. Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation. Int J Cancer 2005; 117: 755-763.
27. Yang S, Lim M, Pham LK, Kendall SE, Reddi AH, Altieri DC et al. Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-Terminal kinase pathways. Cancer Res 2006; 66: 4285-4290.
28. Wang J, Jin Y, Xu Z, Zheng Z, Wan S. Involvement of caspase-3 activity and survivin downregulation in cinobufocini-induced apoptosis in A 549 cells. Exp Biol Med (Maywood) 2009; 234: 566-572.
29. Zhang X, Xie X, Heckmann BL, Saarinen AM, Czyzyk TA, Liu J. Target disruption of G0/G1 Switch Gene 2 enhances adipose lipolysis, alters hepatic energy balance, and alleviates high fat diet-induced liver steatosis. Diabetes 2013; e-pub ahead of print 5 November 2013; doi:10.2337/db13-1422.
30. Chen G, Deng C, Li YP. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 2012; 8: 272-288.
31. Cao X, Chen D. The BMP signaling and in vivo bone formation. Gene 2005; 357: 1-8.
32. Lechler P, Schaumburger J, Kock FX, Balakrishnan S, Doukas S, Prantl L et al. The oncofetal gene survivin promotes cell proliferation and survival in primary human osteoblastic cells. Calcif Tissue Int 2011; 89: 211-220.
33. Jee WS, Yao W. Overview: Animal models of osteopenia and osteoporosis. J Musculoskelet Neuronal Interact 2001; 1: 193-207.
34. Bhargavan B, Gautam AK, Singh D, Kumar A, Chaurasia S, Tyagi AM et al. Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling. J Cell Biochem 2009; 108: 388-399.
35. Gautam AK, Bhargavan B, Tyagi AM, Srivastava K, Yadav DK, Kumar M et al. Differential effects of formononetin and cladrin on osteoblast function, peak bone mass achievement and bioavailability in rats. J Nutr Biochem 2011; 22: 318-327.
36. Trivedi R, Kumar S, Kumar A, Siddiqui JA, Swarnkar G, Gupta V et al. Kaempferol has osteogenic effect in ovariectomized adult Sprague-Dawley rats. Mol Cell Endocrinol 2008; 289: 85-93.
37. Tyagi AM, Gautam AK, Kumar A, Srivastava K, Bhargavan B, Trivedi R et al. Medicarpin inhibits osteoclastogenesis and has nonestrogenic bone conserving effect in ovariectomized mice. Mol Cell Endocrinol 2010; 325: 101-109.
38. Tyagi AM, Srivastava K, Mansoori MN, Trivedi R, Chattopadhyay N, Singh D. Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: A new candidate in the pathogenesis of osteoporosis. PLoS One 2012; 7: E44552.
39. Tyagi AM, Srivastava K, Kureel J, Kumar A, Raghuvanshi A, Yadav D et al. Premature T cell senescence in Ovx mice is inhibited by repletion of estrogen and medicarpin: A possible mechanism for alleviating bone loss. Osteoporos Int 2012; 23: 1151-1161.
40. Pandey R, Gautam AK, Bhargavan B, Trivedi R, Swarnkar G, Nagar GK et al. Total extract and standardized fraction from the stem bark of Butea monosperma have osteoprotective action: Evidence for the nonestrogenic osteogenic effect of the standardized fraction. Menopause 2010; 17: 602-610.
41. Hara K, Kobayashi M, Akiyama Y. Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats. Bone 2002; 31: 575-581.